Mission Statement
The VMAC aims to provide a center of expertise in all areas of monoclonal antibody production and technology. Our mission is to make state of the art hybridoma/monoclonal antibody technology cost effective and readily available to Vanderbilt Investigators. We also serve as a low cost center for purification, quality control, and distribution of useful antibodies to researchers both inside and outside Vanderbilt.
VMAC Staff
Robert Carnahan- Director
Kimberly Cook - Research Assistant: Antibody Purification
\
Tracy Triplett - Research Assistant: Hybridoma Generation
Matt Goff- Research Assistant: Antigen Purification
Albert B. Reynolds - Executive Director